All 1 tracked stories fall under one category: consumer-trends. Rhode Island is most often covered alongside CVS Health, which appears in 1 of these 1 story. We currently track 1 Retail story that mention Rhode Island, all published on July 11, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Rhode Island
All 1 tracked stories fall under one category: consumer-trends. Rhode Island is most often covered alongside CVS Health, which appears in 1 of these 1 story. We currently track 1 Retail story that mention Rhode Island, all published on July 11, 2026. Each carries 1 original source on average.
Stories tracked
1
Sources per story
1
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Retail stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Rhode Island. Shared-story counts are live from our verified record — not editorial picks.
CVS Health’s $36.5 million settlement over Medicaid overbilling for insulin pens threatens to erode consumer confidence in its retail pharmacy operations. The decade-long scheme of excessive refills raises questions about pharmacy integrity and could prompt operational overhauls that reshape the competitive landscape.
Rhode Island is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.